logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
P

Pharmaceutical Statistics

IF1.4
论文数51
被引数
期刊论文 51
发表时间
delete
Evolving Variants, Shifting Outcomes: Implications for Nonconcurrent Controls in Platform Trials for COVID-19变异株的演变与结局的转移：对COVID-19平台试验中非同期对照的启示
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteWatanabe, Shin; Shimizu, Yosuke; Sato, Hiroyuki; Uemura, Yukari; Hirakawa, Akihiro
delete分享
delete收藏
Diagnostic Accuracy Measures and Optimal Cut-Off Points for Nested Disease Subtypes Within the Disease Ordinal States嵌套于疾病等级状态中的嵌套疾病亚型的诊断准确性指标与最佳临界点
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteSamawi, Hani; Alsharman, Marwan; Kersey, Jing
delete分享
delete收藏
A Constrained Hierarchical Bayesian Model Considering Latent Biomarker Subgroups for Time-To-Event Endpoints in Randomized Phase II Trials考虑潜在生物标志物亚组的时间-事件终点的随机II期试验的约束层次贝叶斯模型
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteHuang, Yifei; Takeda, Kentaro; Zhao, Yongyun
delete分享
delete收藏
Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects Model随机效应模型下国际多中心临床试验的一致性评估与区域性样本量计算
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteRen, Xinru; Xu, Jin
delete分享
delete收藏
A Dose-Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D-Optimality基于贝叶斯四参数逻辑模型的惩罚D-最优性药物组合剂量寻找设计
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
deleteOAAI
deleteAjimi, Maxine; Webb, Benjamin; Wheeler, Graham M.; Marshall, Jayne; Mander, Adrian P.
delete分享
delete收藏
A Seamless Two-Stage Phase I/II Trial Design With Backfill and Joint Monitoring for Dose Optimization无缝两阶段I/II期试验设计，含回填和联合监测用于剂量优化
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete1
PREAI
deleteTakeda, Kentaro; Zhu, Jing; Yimer, Belay B.; Hirakawa, Akihiro
delete分享
delete收藏
RABOTS: A Randomized Adaptive Bayesian Optimization Two-Stage Seamless Design for Dose Optimization and Proof-of-Concept EvaluationRABOTS：一种用于剂量优化和概念验证评估的随机自适应贝叶斯优化两阶段无缝设计
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteZhu, Xiaochen; Li, Yiwei; Wu, Jiaju; Tang, Yike; Liu, Liangang; Huang, Shu-Pang; Hsieh, Hsin-Ju
delete分享
delete收藏
Predictive Biomarker Graphical Approach (PRIME) for Precision MedicinePRIME（预测性生物标志物图形方法）用于精准医学
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteD'Angelo, Gina; Tian, Xiaowen; Deng, Chuyu; Zhou, Xian
delete分享
delete收藏
Phase III Probability of Success When Early Development Is Based on a Putative Surrogate Endpoint: A Vaccine Efficacy Case Study基于假定性替代终点的早期开发中III期试验成功的概率：一项疫苗效力案例研究
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteCallegaro, Andrea; Solmi, Francesca; Noirjean, Silvia; Conti, Valentino; Tibaldi, Fabian; Eletti, Alessia
delete分享
delete收藏
An Ensemble Classifier for Ordinal Outcomes in High-Dimensional Genomics Data高维基因组数据中序数结果的集成分类器
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
deleteOAAI
deleteRathnasekara, Heranga K.; Sikdar, Sinjini
delete分享
delete收藏
Integrating Preclinical Insights for Adaptive Dose Escalation in Phase I Oncology Trials将预临床见解整合到肿瘤学I期试验的适应性剂量递增中
deletePharmaceutical Statistics
IF1.4
delete2026-05-01
delete0
PREAI
deleteBarnett, Helen; Guhl, Melanie; Di Stefano, Fulvio; Skanji, Donia; Guilleminot, Sandrine; Saint-Hilary, Gaelle; Mozgunov, Pavel; Riviere, Marie-Karelle
delete分享
delete收藏
Evaluating Safety Rules in Ongoing Dose-Escalation Trials Using BOIN: A Comparative Analysis of Criteria and Their Impact on Dose-Level Safety Assessments使用BOIN评估正在进行剂量递增试验中的安全规则：对标准及其对剂量水平安全评估影响的比较分析
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteEnglert, Stefan; Prior, Thomas J.; Mitra, Anirban; Sanusi, Busola; Zhang, Liangcai; Di Scala, Lilla
delete分享
delete收藏
Using Off-Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy采用离治疗顺序多重插补法处理二分类结局以应对由治疗策略处理的中途事件
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteRehal, Sunita; Best, Nicky; Watts, Sarah; Drury, Thomas
delete分享
delete收藏
Bayesian Power-Based Sample Size Determination for Single-Arm Clinical Trials With Time-to-Event Endpoints基于贝叶斯功效的生存时间终点单臂临床试验样本量确定
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHoriguchi, Go; Yokota, Isao; Teramukai, Satoshi
delete分享
delete收藏
Within-Trial Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation试验内预后评分调整是目标最大似然估计
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHojbjerre-Frandsen, Emilie; Schuler, Alejandro
delete分享
delete收藏
Penalized Variable Selection for Joint AFT Random-Effect Model With Clustered Competing-Risks Data带聚类竞争风险数据的联合AFT随机效应模型的惩罚变量选择
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHao, Lin; Do Ha, Il
delete分享
delete收藏
Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification Bias在验证偏倚下对部分Youden指数置信区间的估计方法学方法
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteJia, Sihan; Wang, Shirui; Qin, Gengsheng
delete分享
delete收藏
An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size针对具有信息性簇大小的有序结局聚集数据的关联检验
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteSenevirathne, Hasika K. Wickrama; Dutta, Sandipan
delete分享
delete收藏
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance Bias早期临床试验中的配对和AB/BA交叉设计：对个体内方差偏差的深入探讨
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteWolfsegger, Martin J.; Xu, Peixin; Cotterill, Amy; Schutz, Helmut; Jaki, Thomas F.
delete分享
delete收藏
New, Shorter Small-Sample Intervals for Vaccine Efficacy新、更短的疫苗效力的样本量较小置信区间
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteGasparini, Mauro; Di Trani, Vincenzo; Ratta, Marco
delete分享
delete收藏